{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04979247",
            "orgStudyIdInfo": {
                "id": "VOLITION"
            },
            "organization": {
                "fullName": "The Cleveland Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Intravenous Oliceridine and Opioid-related Complications",
            "officialTitle": "Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study",
            "therapeuticArea": [
                "Other"
            ],
            "study": "intravenous-oliceridine-and-opioid-related-complications"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-09-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-07-16",
            "studyFirstSubmitQcDate": "2021-07-26",
            "studyFirstPostDateStruct": {
                "date": "2021-07-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "The Cleveland Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The investigator will evaluate the side effects of oliceridine.",
            "detailedDescription": "The investigator will evaluate the side effects of oliceridine. Limited information suggests that oliceridine may cause fewer side effects than the standard opioids given post surgery. Oliceridine is effective for treating acute pain, and is approved by the FDA. Patients will wear a device that continuously monitors breathing. Data from this monitor will be blinded to the clinical staff. Primary Aims include: The investigators will evaluate the proportion of patients having an adjudicated meaningful respiratory compromise with a specified precision of 0.15 using a 95% confidence interval at 24 hours post first study dose."
        },
        "conditionsModule": {
            "conditions": [
                "Major Surgery"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Oliceridine",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive Oliceridine for pain control.",
                    "interventionNames": [
                        "Drug: Oliceridine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Oliceridine",
                    "description": "Near the end of surgery, patients will be given \u22641.5 mg of oliceridine as a bolus. Postoperatively, patient-controlled analgesia (PCA) will be started with no background infusion, demand doses of 0.35 mg, with a 6 minute lock-out. Additional boluses (\u22641 mg) of oliceridine will be given as deemed necessary (based on NRS score and clinical assessment of the patient) as soon as 15 minutes after the initial 1.5 mg loading dose. In addition to supplemental 1 mg bolus doses, the PCA demand dose can be increased to a maximum of 0.5 mg oliceridine.",
                    "armGroupLabels": [
                        "Oliceridine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of patients who have respiratory compromise.",
                    "description": "Respiratory compromise will be defined by a collapsed (one or more) composite of 1) end-tidal carbon dioxide \\<15mmHg for \u22653 minutes; 2) respiratory rate \u22645 breaths/minute for \u22653 minutes; 3) SpO2 \u2264 85% for \u22653 minutes; 4) Apnea episode lasting \\>30 seconds; 5)any serious respiratory event.",
                    "timeFrame": "24 hours post first study dose."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Cumulative duration of oxygen saturation < 90%",
                    "description": "The sum of minutes with SpO2\\<90% from monitoring data",
                    "timeFrame": "48 hours post first study dose."
                },
                {
                    "measure": "Cumulative duration of respiratory rate < 8 breaths/ minute",
                    "description": "The sum of minutes with respiratory rate \\< 8 from monitoring data",
                    "timeFrame": "48 hours post first study dose."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* \u226518 years old\n* American Society of Anesthesiologists physical status 1-4\n* Scheduled for major noncardiac surgery expected to last at least 2 hours\n* Expected to remain hospitalized at least two postoperative nights\n* Scheduled for general endotracheal, spinal anesthesia, or the combination\n* Expected to require substantial opioid analgesia, defined as \u226520 mg morphine equivalents\n* Expected to have patient-controlled intravenous analgesia.\n\nExclusion Criteria:\n\n* Are demented or otherwise cannot provide valid consent\n* Have contraindications to oliceridine\n* Used legal or illegal opioids chronically, defined as \\>15 mg morphine equivalents for \\>15 days during the month before consenting by history\n* Have language, vision, or hearing impairments that may compromise continuous ventilation monitoring\n* Have planned epidural anesthesia/analgesia\n* Planned spinal morphine administration\n* Are designated Do Not Resuscitate, hospice, or receiving end of life therapy\n* Are expected to require postoperative mechanical ventilation or ICU admission\n* Are expected to receive intrathecal opioids\n* Are expected to receive gabapentin, pregabalin or other analgesic adjuvants\n* Use oxygen at home\n* Are unwilling or unable to comply fully with study procedures (including not tolerating the capnography cannula)\n* Are known to be pregnant or breastfeeding\n* Use CPAP at home\n* Have previously participated in the trial",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Roberta Johnson",
                    "role": "CONTACT",
                    "phone": "216-444-9950",
                    "email": "johnsor13@ccf.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Daniel I Sessler, MD",
                    "affiliation": "The Cleveland Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Wake Forest Bapist Medical Center",
                    "status": "RECRUITING",
                    "city": "Winston-Salem",
                    "state": "North Carolina",
                    "zip": "27157",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ashish K Khanna, MD",
                            "role": "CONTACT",
                            "phone": "336-716-4498",
                            "email": "akhanna@wakehealth.edu"
                        },
                        {
                            "name": "Lynnette Harris",
                            "role": "CONTACT",
                            "email": "lcharris@wakehealth.edu"
                        },
                        {
                            "name": "Ashish K Khanna, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.09986,
                        "lon": -80.24422
                    }
                },
                {
                    "facility": "Cleveland Clinic Fairview Hospital",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44111",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Roberta Johnson",
                            "role": "CONTACT",
                            "phone": "216-444-9950",
                            "email": "johnsor13@ccf.org"
                        },
                        {
                            "name": "Eitan Nemirovsky Scher, MD",
                            "role": "CONTACT",
                            "phone": "216-476-0318",
                            "email": "scherne@ccf.org"
                        },
                        {
                            "name": "Sabry Ayad, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Cleveland Clinic Main Campus",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Roberta Johnson",
                            "role": "CONTACT",
                            "phone": "216-444-9950",
                            "email": "johnsor13@ccf.org"
                        },
                        {
                            "name": "Daniel Sessler, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}